General Announcement::MEDIA RELEASE - FDA GRANTS CONDITIONAL IDE APPROVAL FOR CHOCOLATE TOUCH CLINICAL TRIALS
Issuer & Securities
Issuer/ Manager
QT VASCULAR LTD.
Securities
QT VASCULAR LTD. - SG2G82000008 - 5I0
Stapled Security
No
Announcement Details
Announcement Title
General Announcement
Date &Time of Broadcast
19-Sep-2016 18:13:10
Status
New
Announcement Sub Title
MEDIA RELEASE - FDA GRANTS CONDITIONAL IDE APPROVAL FOR CHOCOLATE TOUCH CLINICAL TRIALS
Announcement Reference
SG160919OTHRI8PR
Submitted By (Co./ Ind. Name)
Eitan Konstantino
Designation
Chief Executive Officer
Effective Date and Time of the event
19/09/2016 18:00:00
Description (Please provide a detailed description of the event in the box below)
Please refer to the attached.
Attachments
SGX Announcement - QT Vascular Receives IDE Approval for Chocolate Touch.pdf
Total size =160K
Related Announcements
Related Announcements